Work at RxSight®

World Leader in Adjustable Lens Technology for Cataract Patients

Our team here at RxSight is an easygoing, energetic, and hardworking group of talented employees who are passionate about what they do. We are proud to be an equal opportunity employer and are committed to building a diverse, dynamic, and forward-thinking employee community that encourages and inspires teamwork to achieve the best outcomes for themselves and the company as well as the doctors and patients we serve.

View Open Positions
RxSight team group photo

Why Work at RxSight?

Flexible Schedule

We offer flexible working arrangements in a way that can provide mutually beneficial options for both the company and its employees including working partially from home or remotely for selected office-based positions, or alternate workweek schedules (9/80) for eligible employees, generous personal time off, and company paid holidays.

Employee recognition

We celebrate success and value employee recognition. We have developed our incredible Eye Inspire program to encourage peer-to-peer recognition of our employees throughout the year as well as our yearly Spectocular Award program which recognizes outstanding achievements by employees who are nominated by our management team.

Internship Opportunities

We offer internship programs that provide real work experience to university students based on business needs. There are many career development opportunities in various departments that allow students to explore their passions while working on projects that matter. Internship openings can be found on our careers page when available.

Fun Atmosphere

We also have fun at RxSight! From food trucks to fitness walks to refreshing smoothies and many other team building activities and events. We proudly give back to the community by sponsoring The Foundation Fighting Blindness in Orange County and participating in their yearly Vision Walk to help raise funds for sight-saving research.

Employee Benefits & Investment

We have designed our benefits offerings to support what matters most to our employees. We offer a comprehensive package of compensation and benefits to support your well-being, your family, and your future.

  • Medical, dental, and vision coverage
  • Company-paid life insurance policy
  • Company-paid short-term and long-term disability insurance
  • HSA/FSA and supplemental health plans
  • Employee assistance programs and confidential mental wellness benefits
  • 401(k) matching
  • RxSight stock options
  • Employee stock purchase plan

Current Job Openings

RxSight logo
Facebook-f Instagram Twitter Youtube Linkedin-in

Important Safety Information

Approved use: The Light Adjustable Lens and Light Delivery Device (LDD) system is approved for patients who have a cataract and need surgery for it, have corneal astigmatism (at least 0.75 diopters) before surgery, and do not have preexisting macular disease.

Who should not receive this treatment? The Light Adjustable Lens and LDD system should not be used if you are taking medications that may increase your sensitivity to ultraviolet (UV) light; if you are taking a medication that is considered harmful to your retina; if you have a history of herpes eye infection or uncontrollable eye movements (nystagmus); or if you are unable to comply with your doctor’s schedule of LDD light treatments and instructions for wearing special UV-protective glasses for several weeks following cataract surgery.

What warnings should I be aware of? Preexisting macular disease and certain eye conditions may increase the risk of complications. Your doctor will determine if you are a good candidate for the Light Adjustable Lens. If you have any complications during your cataract surgery before the Light Adjustable Lens is implanted, you may need to have another intraocular lens (IOL) implanted instead of the Light Adjustable Lens.

What precautions should I be aware of? The safety and effectiveness of the Light Adjustable Lens and LDD have not been established in patients with certain preexisting eye conditions or in patients who experience certain complications during cataract surgery. You should discuss these issues with your doctor. Following surgery, you must wear the special UV-protective glasses during all waking hours for about 4 to 5 weeks and comply with your doctor’s schedule of LDD light treatments. Failure to wear the UV-protective glasses can result in an unpredicted vision change or loss of vision quality after exposure to UV light, such as from sunlight. This may require a second surgery to remove the Light Adjustable Lens from your eye and replace it with another IOL.

What are the potential risks? As with any surgical procedure, there are risks associated with cataract surgery and IOL implantation. Please discuss these risks with your doctor. Potential risks associated with LDD light treatments include mild alterations to color perceptions; temporary scratchiness, irritation, or dryness to the front part of your eye; and activation of a previously undiagnosed herpes eye infection. Longer lasting and serious adverse events related to the UV light exposure are possible, but rare. There is a small chance that your vision could be made worse or that you may require additional surgery as a result of a complication.

Caution: Federal law restricts this device to sale by or on the order of a physician.

Click here for more patient information

©2023 RxSIGHT. All Rights Reserved. COM-1043 Rev. B

LAL patients saw nearly as well without glasses (UCDVA) as control patients did with glasses (BCDVA).

The LAL provides optimized vision for patient satisfaction.2

LAL patients saw nearly as well without glasses (UCDVA) as control patients did with glasses (BCDVA).

Since the LAL is a monofocal lens, there is low risk of dysphotopsias caused by splitting light, leading to potentially enhanced vision and patient satisfaction.

LAL patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.

The LAL offers LASIK-like accuracy in cataract surgery.2,3

92% of eyes (N = 391) achieved results within 0.50 D of target manifest refraction spherical equivalent (MRSE).

Patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.

The study was a prospective, controlled, multicenter, 12-month study of 600 patients (ITT population) randomized to receive implantation with the RxSight LAL (N = 403) or a commercially available monofocal IOL (N = 197). Effectiveness analyses included 391 LAL patients and 193 control patients. Primary safety variables included best spectacle-corrected visual acuity (BSCVA) at 6 months and incidence of sight-threatening complications and adverse events. Primary effectiveness variables included percent reduction in manifest cylinder at 6 months, percent mean absolute reduction in MRSE at 6 months, and rotation of meridian of LAL at 6 months. Percent of eyes with an uncorrected visual acuity (UCVA) of 20/20 or better at six months post-operatively compared between the LAL treatment group and the monofocal control group was a secondary endpoint.

The Light Adjustable Lens corrects down to 0.5 diopters of postoperative cylinder.

The LAL corrects down to 0.5 diopters of astigmatism, which is the lowest level approved to be treated.

The ability to treat 0.50 D of postoperative cylinder makes the Light Adjustable Lens the only IOL in the United States approved to correct this level of vision-altering astigmatism. Astigmatism of as little as 0.50 D can reduce visual acuity by one line, and the impact on dynamic, functional visual acuity and low-contrast acuity is even greater.1